Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Cryo Cell International Inc's Business Segments
Cryo Cell International Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
3
Largest Segment
Umbilical Cord Blood and Cord Tissue Stem Cell Service
Total Revenue
$ 8
Regions Reported
-
Revenue Share by Reportable Segment - Q1 FY2026
- Umbilical Cord Blood and Cord Tissue Stem Cell Service99.5%
- Prepacytecb0.5%
- Public Cord Blood Banking0%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Umbilical Cord Blood and Cord Tissue Stem Cell Service | $ 8 | 99.5% |
| Prepacytecb | $ 0 | 0.5% |
| Public Cord Blood Banking | $ 0 | 0% |
Revenue by Product & Service Category - Q1 FY2026
- Processing and Storage Fees99.5%
- Product0.5%
- Public Banking0%
Revenue by Product & Service Category - Q1 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Processing and Storage Fees | $ 8 | 99.5% |
| Product | $ 0 | 0.5% |
| Public Banking | $ 0 | 0% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Cryo Cell International Inc
Cryo-Cell International Inc is a global biotechnology company specializing in stem cell cryopreservation. It was founded in 1989 and is headquartered in Oldsmar, Florida. The company is dedicated to providing families with a secure and reliable means of preserving their newborn's stem cells for potential future medical use.
Cryo-Cell International operates state-of-the-art laboratories that are equipped with cutting-edge technologies and adhere to rigorous quality standards. They have been accredited by various regulatory bodies, including the AABB (formerly known as the American Association of Blood Banks) and the FDA (Food and Drug Administration). These certifications ensure that their operations meet the highest standards of quality and safety.
The company's primary service is the preservation of umbilical cord blood stem cells. Cord blood is collected immediately after birth and contains a rich source of stem cells that can be used in the treatment of numerous diseases and conditions. Cryo-Cell International uses a proprietary cryopreservation process to freeze and store these stem cells, ensuring their long-term viability and potency.
Cryo-Cell International maintains a large repository of cryopreserved stem cells, which is constantly expanding as more families choose to preserve their newborn's cord blood. The company also provides comprehensive testing and analysis services, allowing clients to learn more about their stored stem cells and how they could potentially be used in future medical treatments.
In addition to umbilical cord blood banking, Cryo-Cell International offers other stem cell banking services, such as the preservation of dental pulp stem cells and adipose tissue-derived stem cells. These alternative sources of stem cells provide additional opportunities for medical intervention and regenerative therapies.
In recent years, Cryo-Cell International has expanded its operations globally, establishing international subsidiaries in countries such as Brazil, Colombia, India, and China. This expansion allows the company to reach a wider customer base and cater to the growing demand for stem cell banking services worldwide.
As a pioneer in the field of stem cell preservation, Cryo-Cell International actively participates in scientific research and clinical trials. They collaborate with leading medical institutions and researchers to advance the understanding and application of stem cells in various therapeutic areas.
Cryo-Cell International is committed to providing families with peace of mind by offering a secure and reliable means of preserving their newborn's stem cells. By harnessing the potential of stem cells, they aim to contribute to the advancement of regenerative medicine and provide hope for future medical breakthroughs.
Cryo-Cell International operates state-of-the-art laboratories that are equipped with cutting-edge technologies and adhere to rigorous quality standards. They have been accredited by various regulatory bodies, including the AABB (formerly known as the American Association of Blood Banks) and the FDA (Food and Drug Administration). These certifications ensure that their operations meet the highest standards of quality and safety.
The company's primary service is the preservation of umbilical cord blood stem cells. Cord blood is collected immediately after birth and contains a rich source of stem cells that can be used in the treatment of numerous diseases and conditions. Cryo-Cell International uses a proprietary cryopreservation process to freeze and store these stem cells, ensuring their long-term viability and potency.
Cryo-Cell International maintains a large repository of cryopreserved stem cells, which is constantly expanding as more families choose to preserve their newborn's cord blood. The company also provides comprehensive testing and analysis services, allowing clients to learn more about their stored stem cells and how they could potentially be used in future medical treatments.
In addition to umbilical cord blood banking, Cryo-Cell International offers other stem cell banking services, such as the preservation of dental pulp stem cells and adipose tissue-derived stem cells. These alternative sources of stem cells provide additional opportunities for medical intervention and regenerative therapies.
In recent years, Cryo-Cell International has expanded its operations globally, establishing international subsidiaries in countries such as Brazil, Colombia, India, and China. This expansion allows the company to reach a wider customer base and cater to the growing demand for stem cell banking services worldwide.
As a pioneer in the field of stem cell preservation, Cryo-Cell International actively participates in scientific research and clinical trials. They collaborate with leading medical institutions and researchers to advance the understanding and application of stem cells in various therapeutic areas.
Cryo-Cell International is committed to providing families with peace of mind by offering a secure and reliable means of preserving their newborn's stem cells. By harnessing the potential of stem cells, they aim to contribute to the advancement of regenerative medicine and provide hope for future medical breakthroughs.
Cryo-Cell International, Inc. is a leading provider in the field of cord blood and cord tissue banking, as well as other related biobanking services. Their offerings can be categorized into several key segments, products, and services:
1. Cord Blood Banking
a. Private Cord Blood Banking:
- Cryo-Cell provides families the opportunity to store their newborns cord blood for personal use. This involves the collection, processing, and cryopreservation of cord blood stem cells at childbirth, ensuring accessibility for potential future medical treatments.
- Families typically choose this option for various reasons, including the potential for treating genetic disorders, certain types of cancer, and various other medical conditions.
b. Public Cord Blood Banking:
- Cryo-Cell also contributes to public cord blood banks. Families can choose to donate their newborn’s cord blood, which can then be used for research or made available for transplant to patients in need, especially individuals who do not have a suitable matched donor.
Cord Tissue Banking
- In addition to cord blood, Cryo-Cell offers the option to bank umbilical cord tissue. This tissue is rich in mesenchymal stem cells, which have shown potential for treating a variety of medical conditions due to their regenerative properties.
- The collection and storage process is similar to that of cord blood, ensuring that families have access to a rich source of stem cells that could be utilized for future therapeutic purposes.
Stem Cell Services
- Stem Cell Therapy: Cryo-Cell provides information and facilitates access to stem cell therapy opportunities for certain conditions, enhancing the potential use of stored stem cells.
- Research and Development: The company often collaborates with researchers and institutions to explore new therapeutic applications for stem cells derived from cord blood and tissue.
Educational Resources and Support
- Cryo-Cell is committed to informing prospective parents about the benefits and uses of cord blood and tissue banking. They provide educational materials, webinars, and consultations to help families make informed decisions regarding stem cell storage.
- The company offers comprehensive guidance during the process of collection and storage, ensuring parents feel supported throughout the experience.
International Collection and Processing
- Recognizing the global need for stem cell resources, Cryo-Cell has established international partnerships and systems for the collection and preservation of cord blood outside of the United States. This expansion allows families across various regions to access high-quality cord blood banking services.
Quality Assurance and Compliance
- Cryo-Cell adheres to strict regulatory standards and guidelines to ensure the highest quality of service in collection, processing, and storage. This includes compliance with the FDA and AABB (American Association of Blood Banks) requirements, ensuring safety and efficacy in their offerings.
Family Plans and Financing Options
- Cryo-Cell provides various plans tailored to fit different family needs and budgets. This includes flexible payment options and promotional offers to make stem cell banking more accessible for families.
- They may also provide financing plans for families looking to secure long-term health resources without the immediate upfront costs.
Conclusion
Cryo-Cell International, Inc. is dedicated to pushing the boundaries of regenerative medicine through extensive offerings in cord blood and tissue banking. Their emphasis on quality, customer education, and global accessibility underpins their mission to empower families with the future health resources that stem cells represent. As advancements in medical research continue to evolve, Cryo-Cell’s innovative services aim to play a significant role in harnessing the potential of stem cells for various medical applications.
1. Cord Blood Banking
a. Private Cord Blood Banking:
- Cryo-Cell provides families the opportunity to store their newborns cord blood for personal use. This involves the collection, processing, and cryopreservation of cord blood stem cells at childbirth, ensuring accessibility for potential future medical treatments.
- Families typically choose this option for various reasons, including the potential for treating genetic disorders, certain types of cancer, and various other medical conditions.
b. Public Cord Blood Banking:
- Cryo-Cell also contributes to public cord blood banks. Families can choose to donate their newborn’s cord blood, which can then be used for research or made available for transplant to patients in need, especially individuals who do not have a suitable matched donor.
Cord Tissue Banking
- In addition to cord blood, Cryo-Cell offers the option to bank umbilical cord tissue. This tissue is rich in mesenchymal stem cells, which have shown potential for treating a variety of medical conditions due to their regenerative properties.
- The collection and storage process is similar to that of cord blood, ensuring that families have access to a rich source of stem cells that could be utilized for future therapeutic purposes.
Stem Cell Services
- Stem Cell Therapy: Cryo-Cell provides information and facilitates access to stem cell therapy opportunities for certain conditions, enhancing the potential use of stored stem cells.
- Research and Development: The company often collaborates with researchers and institutions to explore new therapeutic applications for stem cells derived from cord blood and tissue.
Educational Resources and Support
- Cryo-Cell is committed to informing prospective parents about the benefits and uses of cord blood and tissue banking. They provide educational materials, webinars, and consultations to help families make informed decisions regarding stem cell storage.
- The company offers comprehensive guidance during the process of collection and storage, ensuring parents feel supported throughout the experience.
International Collection and Processing
- Recognizing the global need for stem cell resources, Cryo-Cell has established international partnerships and systems for the collection and preservation of cord blood outside of the United States. This expansion allows families across various regions to access high-quality cord blood banking services.
Quality Assurance and Compliance
- Cryo-Cell adheres to strict regulatory standards and guidelines to ensure the highest quality of service in collection, processing, and storage. This includes compliance with the FDA and AABB (American Association of Blood Banks) requirements, ensuring safety and efficacy in their offerings.
Family Plans and Financing Options
- Cryo-Cell provides various plans tailored to fit different family needs and budgets. This includes flexible payment options and promotional offers to make stem cell banking more accessible for families.
- They may also provide financing plans for families looking to secure long-term health resources without the immediate upfront costs.
Conclusion
Cryo-Cell International, Inc. is dedicated to pushing the boundaries of regenerative medicine through extensive offerings in cord blood and tissue banking. Their emphasis on quality, customer education, and global accessibility underpins their mission to empower families with the future health resources that stem cells represent. As advancements in medical research continue to evolve, Cryo-Cell’s innovative services aim to play a significant role in harnessing the potential of stem cells for various medical applications.